Akihiro Watanabe
Niigata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Favorable outcomes of de novo advanced phases of pediatric chronic myeloid leukemia in the tyrosine kinase inhibitor era.
Journal: International journal of hematology
Published: December 15, 2024
Growth retardation and adult height in pediatric patients with chronic-phase chronic myeloid leukemia treated with tyrosine kinase inhibitors.
Journal: Leukemia
Published: August 11, 2024
Salvage hematopoietic cell transplantation for children with acute myeloid leukemia relapsed after first transplantation: a Japanese national registry study.
Journal: Bone marrow transplantation
Published: June 30, 2024
A higher CD34 + cell dose correlates with better event-free survival after KIR-ligand mismatched cord blood transplantation for childhood acute myeloid leukemia.
Journal: Journal of hematology & oncology
Published: April 01, 2024
Optimizing transplantation procedures through identification of prognostic factors in second remission for children with acute myeloid leukemia with no prior history of transplant.
Journal: Haematologica
Published: March 22, 2023
Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia.
Journal: Pediatric blood & cancer
Published: January 12, 2022
Acute promyelocytic leukemia with a cryptic insertion of RARA into TBL1XR1.
Journal: Genes, chromosomes & cancer
Published: May 21, 2019
Sequential use of second-generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
Journal: Pediatric blood & cancer
Published: April 16, 2018
Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation.
Journal: Cancer research
Published: March 26, 2018
Clinical characteristics of pediatric patients with myeloid sarcoma without bone marrow involvement in Japan.
Journal: International journal of hematology
Published: March 01, 2018
Flow cytometric analysis as an additional predictive tool of treatment response in children with chronic-phase chronic myeloid leukemia treated with imatinib.
Journal: Pediatric blood & cancer
Published: July 25, 2016
Last Updated: 09/26/2026